Close Menu
Home › Technology › Microarrays & Multiplexing

Microarrays & Multiplexing

News on microarrays, multiplexing, genotyping, cytogenetics, gene expression profiling in genetics, genomics, and molecular diagnostics.

Custom NanoString Assay Detects Bowel Cancer Subtypes, May Help Guide Therapies

Premium

The researchers have used nCounter, an FDA-cleared platform from NanoString Technologies, to develop their gene expression assay for subtype classification.

Agendia, Imegen Ink Distribution Deal for Breast Cancer Tests in Spain, Portugal

MammaPrint classifies patients as either high risk or low risk of recurrence over a 10-year period while BluePrint classifies patients by breast cancer subtype.

Almac Assay's Ability to Stratify Esophageal Cancer Patients Demonstrated by UK Researchers

Premium

The test relies on a signature that Almac developed for stratifying breast cancer patients, but which, as the researchers showed, can be used in other cancers as well.

WINTHER Trial Highlights Challenges, Potential of Transcriptomics for Precision Oncology

While the study didn't meet its primary endpoint, it showed the potential of transcriptomics to match cancer patients to beneficial treatments.

MiR Scientific Prepares to Launch Tests for Prostate, Bladder Cancer

Premium

The company is seeking NY State approval for its lab, which would allow it to offer both tests as LDTs, hopefully by the end of this year or early next.

Oct
23
Featured Webinar

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries. 

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.